MiniMed Group
MMED
19.11
-0.53
-2.70%
MiniMed Group
US · MMED
#2009 by market cap
Listed 2026
19.11
-0.53
-2.70%
Live - 5344 symbols - heartbeat 219s ago
· 2026-10-08 08:26
Pre-market
19.00
-0.58%
After-hours
19.18
+0.37%
Overnight
19.00
-0.58%
- Market cap
- 5.38B
- P/E (TTM)i
- -16.96
- P/Bi
- 1.49
- EPSi
- -1.30
- Div yieldi
- 0.00%
- 52W posi
- 61%
Reader sentiment
Are you bullish or bearish on MMED?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 103.28% -0.08pp
- Institutions
- 121
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Public Company89.94%
Mutual Fund7.06%
Hedge Fund5.04%
Sovereign Wealth Fund0.70%
Government Pension Fund0.23%
Private Company0.16%
Insurance Company0.14%
Top holders as of 2026-08-11
Medtronic plc
89.86% · 252.81M sh
MFS Investment Management
2.96% · 8.33M sh
Millennium Management LLC
1.09% · 3.06M sh
Citadel Advisors LLC
1.02% · 2.87M sh
Longaeva Partners L.P.
1.00% · 2.81M sh
Sessa Capital IM, L.P.
0.71% · 2.00M sh
BlackRock
0.71% · 2.00M sh
Norges Bank Investment Management
0.70% · 1.96M sh
Rock Springs Capital Management LP
0.54% · 1.52M sh
ExodusPoint Capital Management, LP
0.51% · 1.44M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
37 filings tracked · 30 buys · 6 sells
| Name | Role | Stake |
|---|---|---|
| Medtronic plc | -- | 89.86% |
| Que Dallara | Chief Executive Officer | 0.01% |
| Chad Spooner | Chief Financial Officer | 0.01% |
| Ali Dianaty | Executive VP and Chief Product & Technology Officer | 0.00% |
| Gillian Chandrasena | Chief Human Resources Officer | 0.00% |
| Courtney Nelson Wills | General Counsel | 0.00% |
| John Gyurci | Chief Accounting Officer | 0.00% |
| D. Grossman | Independent Director | -- |
| Glenn Eisenberg | Independent Director | -- |
| Timothy Wicks | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Sheila Denton | General Counsel | Other Acquisition | +58,939 | -- |
| 2026-07-30 | Que Dallara | Chief Executive Officer | Sale to Issuer | -31,350 | $18.15 |
| 2026-07-30 | Ali Dianaty | Executive VP and Chief Product & Technology Officer | Sale to Issuer | -8,012 | $18.15 |
| 2026-07-30 | Courtney Nelson Wills | General Counsel | Sale to Issuer | -1,762 | $18.15 |
| 2026-07-27 | Chad Spooner | Chief Financial Officer | Sale to Issuer | -23,301 | $17.67 |
| 2026-07-27 | Gillian Chandrasena | Chief Human Resources Officer | Sale to Issuer | -2,099 | $17.67 |
| 2026-06-30 | Chad Spooner | Chief Financial Officer | Other Acquisition | +116,607 | -- |
| 2026-06-30 | Que Dallara | Chief Executive Officer | Other Acquisition | +297,618 | -- |
| 2026-06-30 | Ali Dianaty | Executive VP and Chief Product & Technology Officer | Other Acquisition | +131,312 | -- |
| 2026-06-30 | John Gyurci | Chief Accounting Officer | Other Acquisition | +24,244 | -- |
| 2026-06-30 | Gillian Chandrasena | Chief Human Resources Officer | Other Acquisition | +44,188 | -- |
| 2026-06-30 | Courtney Nelson Wills | General Counsel | Other Acquisition | +82,787 | -- |
| 2026-03-24 | Que Dallara | Chief Executive Officer | Sale to Issuer | -4,809 | $16.31 |
| 2026-03-10 | Chad Spooner | Chief Financial Officer | Other Acquisition | +269,401 | -- |
| 2026-03-10 | Que Dallara | Chief Executive Officer | Other Acquisition | +11,446 | -- |
| 2026-03-10 | Que Dallara | Chief Executive Officer | Other Acquisition | +610,117 | -- |
| 2026-03-10 | Ali Dianaty | Executive VP and Chief Product & Technology Officer | Other Acquisition | +191,258 | -- |
| 2026-03-10 | John Gyurci | Chief Accounting Officer | Other Acquisition | +15,322 | -- |
| 2026-03-10 | Gillian Chandrasena | Chief Human Resources Officer | Other Acquisition | +129,765 | -- |
| 2026-03-10 | Courtney Nelson Wills | General Counsel | Other Acquisition | +55,063 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:26:36 · For reference only, not investment advice and not tailored to your situation.